Oyster Point Pharma, Inc. Proceeds from Long-Term Debt Issued
Oyster Point Pharma, Inc. reported Proceeds from Long-Term Debt Issued of $0 for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2022-11-10
- 2022-09-30: Proceeds from Issuance of Long-term Debt 9 month $0.00.
- 2021-09-30: Proceeds from Issuance of Long-term Debt 9 month $40.15M.
- 2020-09-30: Proceeds from Issuance of Long-term Debt 9 month $0.00.
| Period end | Proceeds from Issuance of Long-term Debt 9 month |
|---|---|
| 2022-09-30 | $0.00 10-Q · filed 2022-11-10 |
| 2021-09-30 | $40.15M 10-Q · filed 2022-11-10 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-04 |